The state of Indiana currently has 27 active clinical trials seeking participants for Alzheimer's Disease research studies. These trials are conducted in various cities, including Indianapolis, South Bend, Fort Wayne and Evansville.
Alzheimer's Disease Neuroimaging Initiative 3 (ADNI3)
Recruiting
Since its launch in 2004, the overarching aim of the Alzheimer's Disease Neuroimaging Initiative (ADNI) has been realized in informing the design of therapeutic trials in AD. ADNI3 continues the previously funded ADNI-1, ADNI-GO, and ADNI-2 studies that have been combined public/private collaborations between academia and industry to determine the relationships between the clinical, cognitive, imaging, genetic and biochemical biomarker characteristics of the entire spectrum of Alzheimer's diseas... Read More
Gender:
ALL
Ages:
Between 55 years and 90 years
Trial Updated:
11/18/2024
Locations: Indiana University, Indianapolis, Indiana
Conditions: Mild Cognitive Impairment (MCI), Alzheimer's Disease (AD)
Utilizing Palliative Leaders In Facilities to Transform Care for Alzheimer's Disease
Recruiting
The purpose of this study is to evaluate a comprehensive model for integrating both primary and specialty Palliative Care for older adults with dementia into nursing facilities. Palliative Care is a supportive care approach that aims to improve the quality of life of patients and their families facing serious or life-threatening illnesses, through the prevention and relief of suffering through the treatment of pain and other problems, using physical, psychosocial and spiritual approaches. Pallia... Read More
Gender:
ALL
Ages:
18 years and above
Trial Updated:
10/30/2024
Locations: American Senior Communities, Indianapolis, Indiana
Conditions: Alzheimer Disease
Lifestyle Interventions for the Treatment of Early Onset Alzheimer's Disease Study
Recruiting
The purpose of this study is to generate preliminary data on the benefit of computerized cognitive training and Tai Chi- Qi Gong training in participants with Early-Onset Alzheimer's Disease. It is hypothesized that participants in the experimental training condition will perform better on outcomes related to cognition, functioning, and mood at follow-up compared to participants assigned to the active control condition.
Gender:
ALL
Ages:
Between 40 years and 75 years
Trial Updated:
09/27/2024
Locations: Indiana University, Indianapolis, Indiana
Conditions: Alzheimer Disease, Early Onset